Pleased to inform that a consortium of Japanese doctors has published a paper on LAI. I’m honored to be listed as a co-author. Prof. Orkin encouraged us to form the consortium. We appreciate your support. @profchloeorkin.bsky.social @toshtaniguc.bsky.social onlinelibrary.wiley.com/doi/10.1111/...

We encourage all people living with HIV in Europe to join this short study run by @shareeastlondon.bsky.social & @profchloeorkin.bsky.social to share their experiences with new HIV treatments & conversations with the clinical teams about treatment choices. Visit the page & complete the survey below

Are you: ✅working in a UK sexual health service that provides #PrEP, AND ✅willing to take part in a 15 minute survey? We are conducting a brief survey of sexual health clinics for our #beyondtheclinic study. You can complete the survey here: bit.ly/40weNaX #studyparticipants

Do you live with HIV? Are you in Europe and currently on treatment? Please take part in the Ask Us Europe survey, which aims to improve treatment and care for people with HIV. I am proud to have worked on it with @shareeastlondon.bsky.social and a powerful group of people with HIV. Please share. 🙏

Our latest study to understand the perspective of people living with HIV in Europe is now live! We created it together with an amazing steering group of community members from 17 countries. Please do the survey if you are living with HIV in UK and Europe and SHARE widely !! 🙏🙏🙏🙏

A decline in funding for the HIV response could result in millions of preventable new infections and deaths, with up to 120,000 of these deaths affecting children. International cooperation is essential to sustain the advances we’ve made in HIV prevention, testing, and treatment. bit.ly/43uTfxA

🚨1.25 million people died of TB in 2023 🚨10.8 million new cases of TB were diagnosed in 2023 🚨Multi-drug resistant TB is a public health crisis 🚨US$ 22 billion is needed annually for TB prevention, diagnosis, treatment and care, but funding is being cut. 🚨Poverty fuels TB globally #WorldTBDay2025

#DEI , women’s rights, LGBTQ+ rights, disability rights, global & domestic public health are under attack and being censored in the US. Let’s remember the phenomenon of ‘social contagion’ -the concept that thoughts 💭 can be as contagious as viruses 🦠 and keep committing to celebrating #DEI 🏳️‍🌈🏳️‍⚧️✊🏿♿️

Re-suppression post CAB LA PrEP 083 #CROI2025 9/44 had INSTI resistance before ART 6/6 people suppressed on INSTIs (VL less than / equal to 50 c/ML) 15/16 on other ART 5 further participants from other oral regimens switched to INSTIs afterwards and maintained suppression where data available.

Very strong data from the PILLAR study LA CAB PrEP #CROI2025 60% were cis BiPOC men and were 6% trans men •201 people •0 transmissions •High retention and coverage •22% had not taken PrEP in past 3/12

Brazilian CAB PrEP cohort #CROI2025 •genXpert test at baseline •diverse cohort •86% chose CAB LA •CAB adherence very high •PREP coverage much higher than oral PrEP •no incident infections on CAB •6% did not persist on CAB • 4% switched away due to side effects

Very strong data on LA CAB PrEP from Kaiser Permanente large US real world cohort #CROI2025: •141 received LA CAB •25% had never taken PrEP •75% persistence •No incident infections •> 90% of injections given on time

✅ WHO does not impose lockdowns or policies on countries. It does not have the authority to do this and isn't trying to get it. Only governments can make those decisions. Know the facts ⬇️

ARV session highlights #CROI2025: •Once yrly LEN dose tolerable with good PK •VH499 (capsid inhibitor) with LA potential led to rapid resistance at lowest dose •VH184 3rd gen INSTI appears potent against multiple mutations •ZAB/TAB/LEN-1 breakthru VF (low LEN levels & single bNAb susceptibility)

For those at #CROI2025 there is a ‘Save our Science’ rally this evening at Yerba gardens next to the Moscone centre Non US people CAN attend but you won’t be able to register Hope to see you there @iasociety.bsky.social @hivpxresearch.bsky.social @bhiva.bsky.social

Post from #CROI2025 San Francisco: I have been re-posting recently to amplify voices of US colleagues on the war on science and public health that is taking place in the US and the cuts to public funding for PEPFAR HIV programmes supporting treatment and HIV prevention for millions worldwide.

Happy IWD to all the wonderful, wise women I am so fortunate to have in my life - first and foremost my wife of 24 years, my friends, my colleagues and fellow human rights activists.

Violence against women demands urgent attention. One in three women faces physical or sexual violence, and nearly 25% of workplace violence happens in hospitals or clinics — and women are most affected. #BeijingPlus30 #IWD2025

Here is a blog by Vanessa Apea and I describing the story behind most recent SHARE-net manuscript on the healthcare provider perspective during the 2022/23 #mpox outbreak. The paper has been published in PLOS Global Public Health eur01.safelinks.protection.outlook.com?url=https%3A...

Check out our latest #CDTR - the weekly bulletin for epidemiologists and public health professionals with updates on: ➡️ #STIs ➡️ #chikungunya ➡️ #Ebola ➡️ #measles ➡️ #AvianInfluenza ➡️ #SwineInfluenza ➡️ #influenza & respiratory virus epidemiology. Read full here: bit.ly/41iaY9P #IDsky #EpiSky

In these unthinkably dark days for global public health I’m proud to share the results of this international survey which describes the challenging and distressing experiences of clinicians in 12 countries during the 2022/23 #mpox pandemic. eur01.safelinks.protection.outlook.com?url=https%3A...

The PEPFAR program, which distributes HIV drugs, is estimated to have saved 25 million lives. The Trump administration has stopped it and taken its computer system offline, raising fears the program is done for good. Story by @apoorvanyt.bsky.social [Gift link] nyti.ms/4aCJHSx 2/12

It is important to follow the threat to science as it unfolds in the US. See the thread below

Fantastic to see this profile of our Professor of Infection and Inequities! Congratulations, @profchloeorkin.bsky.social

Thanks QMUL for highlighting this Lancet profile of my work. I’m very honoured to have been profiled & very grateful it foregrounded my work outside of the biomedical model of health & disease & beyond high impact papers. She foregrounded the activism & inclusion work I am most proud of.

Excited to share a new research paper (open access) from our collaboration with @thelovetankcic.bsky.social and the HIV/STI and Emergency Preparedness teams at @who.int.bsky.social doi.org/10.1186/s129...

US based STOMP trial of tecovirimat (tpoxx) for clade 2 mpox fails to demonstrate efficacy benefit. Just as it did not in PALM 007 in clade 1 mpox in DRC. There is no known treatment for mpox Vaccination is the key control strategy and more research is needed. pubmed.ncbi.nlm.nih.gov/38190312/

Kamakura Japan 🇯🇵 - an Autumn/ Fall spectacle to behold 🍁🍂.

Bluesky 🦋 etiquette question: Is it ok to post photos of trees in the good place? @brendacrabtreer.bsky.social @cla-cor.bsky.social

Wonderful to see this incredibly important work foregrounded. Delighted to see @shareeastlondon.bsky.social Dr’s Vanessa Apea and Rebecca Mbewe playing a leading role.

This is so brilliant! Had to repost this from the inimitable @paulsaxmd.bsky.social

Be sure to join @profchloeorkin.bsky.social and me today as we discuss the latest in HIV treatment and prevention!

Cementing the professional legitimacy of 🦋 We now have the journals on #MedSky & #IDSky @jamacurrent.bsky.social @bmj.com @cmicomms.bsky.social (first one?) @eurosurveillance.bsky.social @cidjournal.bsky.social @ofidjournal.bsky.social @thejhi.bsky.social @jclinical-invest.bsky.social

Monday, November 18, 2024 1:00 PM - 2:00 PM Eastern Time (ET) Darcy Wooten and I will be summarising keyHIV studies affecting my practice from IDWeek and Glasgow 2024 for CCO. Join us for this live, interactive webinar CCO doesn’t seem to be on Bluesky yet so check their website.

In addition to skeeting about #HIV #mpox and #inequities and infections, my ‘side hustle’ is speaking up and writing about hidden #disability. Here is my first self-reflective piece published in BMJ Leader #DisabilitySky bmjleader.bmj.com/content/7/2/88

Important editorial! "Women's ability to take a full part in education, to have equal access to health care, to make their own decisions, to have fairly paid work, and to be elevated to positions of authority are fundamental rights that no one should question." www.thelancet.com/journals/lan...

We’re very excited to announce that @shareeastlondon.bsky.social first manuscript from the ILANA study has been published in CIDJournal! You can view it here (open access): doi.org/10.1093/cid/...

New EACS guidance on cancer screening at #HIVGlasgow Screen MSM and TGW>35 and all other men >45 Women >21yrs annually or 3-yearly after three neg PAP smears with CD4 >350 undetectable Tristan Barber asks how this will be achieved with limited capacity

First ever EACS guidelines on chemsex #HIVGlasgow Ask: Do you consume drugs before or during planned sex to facilitate, initiate, prolong, sustain and intensify the encounter? Do you want to see questionnaire score, risk reduction advice and assess level of concern with use @bhiva.bsky.social

CDC 2023 STI report just published today 📌2.4 million STIs reported in the United States in 2023; 📌Gonorrhea ⬇️ by 7% from 2022. 📌Syphilis ⬆️ by only 1% 📌 congenital syphilis increased by 3% . Improving trends but still to high, especially congenital syphilis rates www.cdc.gov/sti-statisti...

HIV CURE: Karine Dube asks : do we need to build in an offer of PrEP to partners of participants of ATI ( analytical treatment interruption) studies ? #HIVGlasgow @bhiva.bsky.social @tristanjbarber.bsky.social

Karine Dube : Ethics of cure- favourable risk/balance ratio. Risks: social, financial, psychological or physical Analytical treatment interruptions affect mental health. Bear in mind: disappointment or stigma associated with viraemia may occur. Calls for justice-informed ATI #HIVGlasgow

#HIVGlasgow @drlaurajwaters.bsky.social shows systematic review of adverse events on statins. Helpful ++ for shared-decision making with PLWH. She mentions potential benefit in vascular dementia and that muscle aches can resolve if statin continued. BHIVA recommends statins for PLWH > 40 yrs

Happy share to evidence synthesis work from @shareeastlondon.bsky.social on re-suppression regimens post CAB+RPV from RCT and RWE and on CVF events from RWE #HIVGlasgow 13 cohorts : CVF was <2% in cohorts with> 75 participants Commonest Post VF regimens RCTs :mostly PI RWE CAB RPV continuation

Hi everyone I have just fled X. I tweet about #HIV #mpox # gender #LGBTQ+ rights #disability rights #inclusion in trials